Suchergebnisse - "Murray, Miranda"

PubPharm (49)

1

Incidence of Antiphospholipid Syndrome : Is Estimation Currently Possible?

enthalten in: European journal of rheumatology | 2023

von Ioannou, Y. | Beukelman, T. | Murray, M. | +1

2

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals

enthalten in: The patient | 2022

von Anderson, S. | Murray, M. | Cella, D. | +9

3

"I feel empowered" : women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain

enthalten in: Culture, health & sexuality | 2021

von Mantsios, A. | Murray, M. | Karver, T. | +13

4

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals

enthalten in: The Patient | 2021

von Anderson, S. | Murray, M. | Cella, D. | +9

5

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals

enthalten in: The Patient | 2021

von Anderson, S. | Murray, M. | Cella, D. | +9

6

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals

enthalten in: The Patient | 2021

von Anderson, S. | Murray, M. | Cella, D. | +9

7

Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV : perspectives of health care providers participating in phase 3 trials

enthalten in: BMC health services research | 2021

von Mantsios, A. | Murray, M. | Karver, T. | +13

8

Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials

enthalten in: BMC health services research | 2021

von Mantsios, A. | Murray, M. | Karver, T. | +13

9

Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV : A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial

enthalten in: AIDS research and human retroviruses | 2021

von Kerrigan, D. | Murray, M. | Sanchez Karver, T. | +8

10

Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks

enthalten in: AIDS and behavior | 2020

von Murray, M. | Antela, A. | Mills, A. | +15

1
2
3
4
5
Nächster »
[5]